Urology - urothelial cancer, Malmö
1 – 10 of 181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
-
Mark
Risk of invasive penile cancer after treatment of penile intraepithelial neoplasia
- Contribution to journal › Article
-
Mark
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer : A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
- Contribution to journal › Article
-
Mark
Pre-treatment metastatic biopsy : a step towards precision oncology for urothelial cancer
- Contribution to journal › Scientific review
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
- Contribution to journal › Debate/Note/Editorial
-
Mark
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer : A Nationwide Population-based Study
- Contribution to journal › Article
-
Mark
Molecular Subtypes of Muscle-Invasive Bladder Cancer
(2025) p.279-295
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
- Contribution to journal › Debate/Note/Editorial
-
Mark
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer : A nationwide population-based cohort study
- Contribution to journal › Article
